Effects of combination therapy: somatostatin analogues and dopamine agonists on GH and IGF1 levels in acromegaly

BACKGROUND AND AIMS: Acromegaly is a complex endocrine disorder caused by excessive secretion of GH, secondary to a GH secreting pituitary adenoma or a mixed pituitary adenoma secreting GH and PRL. METHODS: The aim of this study was to evaluate the effects of combination therapy: dopamine agonist an...

Descripción completa

Detalles Bibliográficos
Autores principales: VALEA, ANA, GHERVAN, CRISTINA, CARSOTE, MARA, MORAR, ANDRA, IACOB, IULIA, TOMESC, FLORICA, POP, DAN DUMITRU, GEORGESCU, CARMEN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632888/
https://www.ncbi.nlm.nih.gov/pubmed/26609262
http://dx.doi.org/10.15386/cjmed-435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632888/
https://www.ncbi.nlm.nih.gov/pubmed/26609262
http://dx.doi.org/10.15386/cjmed-435

Ejemplares similares